Inventor · disambiguated record
Ruben Abagyan
Also filed as: ABAGYAN RUBEN
6 granted patents·11 pending applications·2 citations·filing 2008–2023
66Inventor score
Files withEIL THERAPEUTICS INC5BALA THERAPEUTICS INC2CELYN THERAPEUTICS INC1LOMOND THERAPEUTICS INC1MASSACHUSETTS GEN HOSPITAL1
Top patents by PatentIndex Score
17 records- 0172US9737525B2Small molecule activators of NRF2 pathwayMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Aug 22, 2017·2 cites·11 claims
- 0264US2025376464A1Compounds for treatment a coronavirus infectionTRAWSFYNYDD THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0360US2025163061A1Inhibitors of menin-mll interactionBALA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0454US2025313554A1Ptpn2 inhibitorsNESS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0554US2025282795A1EGFR Inhibitors in cancer treatmentCELYN THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0654US2025270212A1Chimeric compounds useful in treating diseasesPADARN THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0754US2025011319A1SUBSTITUTED 1H-PYRAZOLO [4,3-c] QUINOLINES, METHODS OF PREPARATION, AND USE THEREOFLOMOND THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0854US2025066358A1Inhibitors of Menin-MLL InteractionBALA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0953US2025163066A1PROTACs of MALT1TEGID THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1052US8961987B2Immunogen comprising the HIV GP120 V3 loop in a conformation that induces broadly neutralizing antibodiesZOLLA-PAZNER SUSAN·Filed 2008·Granted Feb 24, 2015·0 cites·35 claims
- 1150US2024043424A1Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitorsEIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1249US2025115577A1BCL-2 InhibitorsEIL THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1349US2023357238A1Compounds having ((3-nitrophenyl)sulfonyl)acetamide as bcl-2 inhibitorsEIL THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1447US11919880B2HCV protease inhibitorsUNIV CALIFORNIA·Filed 2021·Granted Mar 5, 2024·0 cites·6 claims
- 1546US8394811B2Hydrazide compounds as thyroid hormone receptor modulators and uses thereofSAMUELS HERBERT H·Filed 2008·Granted Mar 12, 2013·0 cites·17 claims
- 1645US11697650B2Compounds having tetrahydroindolizine-1-carboxamide as BCL-2 inhibitorsEIL THERAPEUTICS INC·Filed 2022·Granted Jul 11, 2023·0 cites·61 claims
- 1743US11834450B2Compounds having ((3-nitrophenyl)sulfonyl)acetamide as BCL-2 inhibitorsEIL THERAPEUTICS INC·Filed 2022·Granted Dec 5, 2023·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Ruben Abagyan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →